ImageneBio, Inc. (IMA) income statement
IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.81−0.09 (-2.31%)
Close on Nov 18, 2026Market cap $43.25MP/E –Yield –
ImageneBio, Inc. financial ratios
See a number that looks wrong?